Conformation and charge distribution of bicyclic beta-lactams: structure-activity relationships. 1992

B Fernández, and L Carballeira, and M A Ríos
Departamento de Química Física, Facultad de Química, Santiago de Compostela, Spain.

The structures of 7-oxo-1-azabicyclo[3.2.0]heptane and its 4-oxa, 3-ethylene-4-oxa, and 3-ethylene-6-methyl-4-oxa derivatives, and of 8-oxo-1-azabicyclo[4.2.0]octane and its 5-oxa derivative, were studied by ab initio methods. Conformations were refined without constraints using the 4-21G and the 4-21G* basis sets, and energies and charge distributions were improved by single-point 6-31G*/4-21G* calculations. The results are are interpreted in terms of structural trends related to beta-lactamase inhibitor capability.

UI MeSH Term Description Entries
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D047090 beta-Lactams Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria. beta-Lactam,4-Thia-1-Azabicyclo(3.2.0)Heptanes,4-Thia-1-Azabicyclo(4.2.0)Octanes,beta Lactam,beta Lactams
D065093 beta-Lactamase Inhibitors Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. beta Lactamase Inhibitor,beta Lactamase Inhibitors,beta-Lactamase Inhibitor,beta Lactamase Antagonists,Antagonists, beta Lactamase,Inhibitor, beta Lactamase,Inhibitor, beta-Lactamase,Inhibitors, beta Lactamase,Inhibitors, beta-Lactamase,Lactamase Antagonists, beta,Lactamase Inhibitor, beta,Lactamase Inhibitors, beta

Related Publications

B Fernández, and L Carballeira, and M A Ríos
January 2006, Pharmazie in unserer Zeit,
B Fernández, and L Carballeira, and M A Ríos
November 2004, Molecules (Basel, Switzerland),
B Fernández, and L Carballeira, and M A Ríos
January 2000, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
B Fernández, and L Carballeira, and M A Ríos
June 2008, Bioorganic & medicinal chemistry,
B Fernández, and L Carballeira, and M A Ríos
January 1987, NIDA research monograph,
B Fernández, and L Carballeira, and M A Ríos
June 2003, Mini reviews in medicinal chemistry,
B Fernández, and L Carballeira, and M A Ríos
February 2009, The Journal of organic chemistry,
B Fernández, and L Carballeira, and M A Ríos
July 1962, Journal of medicinal and pharmaceutical chemistry,
B Fernández, and L Carballeira, and M A Ríos
January 2002, Organic letters,
B Fernández, and L Carballeira, and M A Ríos
June 2009, Organic & biomolecular chemistry,
Copied contents to your clipboard!